Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEPT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ACBD3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYO9A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
S100PBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LDAH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AEN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARID2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF134 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ICE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNRC6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP155 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIF15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUZ12P1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MBTPS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERCC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MLX - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC41 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD17 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on